News Release

<< Back

Sunesis to Present at the 2013 Stifel Nicolaus Healthcare Conference

09/04/13

SOUTH SAN FRANCISCO, Calif., Sept. 4, 2013 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that Daniel Swisher, Chief Executive Officer and President of Sunesis, will be presenting at the 2013 Stifel Nicolaus Healthcare Conference on Wednesday, September 11th at 4:25 PM Eastern Time at The Four Seasons Hotel in Boston, MA.

A live webcast of the presentation will be available on the Sunesis website at http://ir.sunesis.com. A replay of the webcast will be archived on the "Calendar of Events" page in the Investors and Media section of the Sunesis website for two weeks.

About Sunesis Pharmaceuticals

Sunesis is a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. Sunesis has built a highly experienced cancer drug development organization committed to advancing its lead product candidate, vosaroxin, in multiple indications to improve the lives of people with cancer.

For additional information on Sunesis, please visit http://www.sunesis.com.

CONTACT: Investor and Media Inquiries:
         David PittsArgot Partners
         212-600-1902

         Eric Bjerkholt
         Sunesis Pharmaceuticals Inc.
         650-266-3717

Sunesis Pharmaceuticals, Inc. Logo

Sunesis Pharmaceuticals, Inc.